In Vitro Diagnostics Acquisitions bioMerieux SA Trinity Biotech PLC For approximately €76.8mm ($60mm) (including assets, fees, and earn-outs), bioMerieux has sold its hemostasis product line to diag
Instead of trying to imagine the biological world through genetic shadows, a host of new companies want researchers and physicians to see it in its proteomic reality. by Roger Longman In the last nine